Recruiting at 1 site No phase Obesity

Obesity study: Acute Fasting vs Acute Overfeeding

Official title Thermogenenic Responses to Fasting and Overfeeding in Women

ClinicalTrials.gov ID: NCT06610162

What this study is testing

What it's testing
The study aims to understand why menopause leads to weight gain by comparing how the bodies of pre- and post-menopausal women use energy.
Who it's for
The study is looking for premenopausal and postmenopausal women.
What's involved
Participants will undergo a 24-hour fast and a period of eating extra calories to measure how their bodies burn energy.
Time commitment
The study involves specific periods of fasting and overfeeding, but the total duration is not specified.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65, women only. Healthy volunteers may be eligible.

You may be able to join if

  • for premenopausal women
  • Age 18-45 years.
  • Regular menses (no missed cycles in the previous year; cycle length 25-35 d). for postmenopausal women
  • No menses for at least 12 months
  • Follicular stimulating hormone (FSH) ≥50 mIU/ml.

You likely can't join if

  • Body mass index \> 30 kg/m2
  • Diabetes (fasting glucose \>126 mg/dL).
  • Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \ 5.0 mU/L
  • Uncontrolled hypertension defined as resting systolic BP \>150 mmHg or diastolic BP \>90 mmHg. Additional exclusion criteria for postmenopausal women
  • History or current use of estrogen-based hormonal therapy
  • Women who have undergone surgical menopause. Additional exclusion criteria for premenopausal women
See the full eligibility criteria
Who can join
  • for premenopausal women
  • Age 18-45 years.
  • Regular menses (no missed cycles in the previous year; cycle length 25-35 d). for postmenopausal women
  • No menses for at least 12 months
  • Follicular stimulating hormone (FSH) ≥50 mIU/ml.
  • Women who are within 2 years of the final menstrual period are preferred The primary
What rules you out
  • Body mass index \> 30 kg/m2
  • Diabetes (fasting glucose \>126 mg/dL).
  • Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \ 5.0 mU/L
  • Uncontrolled hypertension defined as resting systolic BP \>150 mmHg or diastolic BP \>90 mmHg. Additional exclusion criteria for postmenopausal women
  • History or current use of estrogen-based hormonal therapy
  • Women who have undergone surgical menopause. Additional exclusion criteria for premenopausal women
  • Current hormonal contraceptive use (past 6 mo.).
  • Pregnant, lactating, or intention to become pregnant during the study period. Participants who fail the thyroid and BP criteria will be considered for enrollment if they receive treatment for these conditions and are...

The study team makes the final eligibility decision.

Where it is enrolling

  • Aurora, Colorado, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Aurora, Colorado, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.